Drug Profile
HIV DNA vaccine - Merck & Co.
Alternative Names: Human Immunodeficiency Virus DNA vaccine - Merck & Co.Latest Information Update: 14 Sep 2022
Price :
$50
*
At a glance
- Originator Merck & Co
- Developer Fresh Tracks Therapeutics
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 20 Mar 2002 A study has been added to the adverse events and Viral Infections immunogenicity sections